Philip Zimmermann
CEO
PREVISION MEDICINE
Zurich, Switzerland
14 profile visitsSpeaker
My organisation
Prevision Medicine is a leader in functional precision medicine dedicated to advancing personalized cancer treatment through innovative, evidence-driven drug-screening technologies. The company’s mission is to provide clinicians with patient-specific treatment options that optimize therapeutic outcomes and improve patient lives. Prevision Medicine offers personalized drug screening tests, by testing live cells from a patient’s biopsy against 100+ cancer treatment options. PrevisionOne, our proprietary ex vivo platform, tests living cancer and healthy cells against a broad panel of drugs and drug combinations before treatment starts. We rank drugs and drug combinations based on their ability to more selectively kill cancer than non-cancer cells. From a patient’s biopsy – liquid or solid -, PrevisionOne delivers an actionable clinical report to support data-driven and personalized treatment strategies across multiple cancer types. Our Motto: Test with Precision, Treat with Confidence
About me
Additional questions
Participant Type
Early-Stage StartupMatchmaking specification
I'm searching for...
Funding (VC, PE, Business Angels, Strategic Investors etc.)Peer-to-Peer Exchange
I'm offering ...
ExpertisePartnership(s) / Collaboration opportunities
Which funding stage applies to you?
Pre-Seed
Speaker sessions (1)
Thursday, 21 May 2026
11:15 - 12:00
Newcomers #2 - Switzerland’s most promising early-stage tech startups
Location:Szenario 2 (Level 0)Track:Newcomers
Experience a transformative journey with our refreshing pitching format: Newcomers.